» Articles » PMID: 2862872

Endogenous Noradrenaline Masks Beta-adrenergic Receptors in Rat Heart Membranes Via Tight Agonist Binding

Overview
Date 1985 Aug 15
PMID 2862872
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The tight binding of noradrenaline (NA) to beta-adrenergic receptors was studied in membranes from the left ventricular myocardium of the rat. Addition of GTP (0.1 mM) to membrane preparations from control rats (NA concentration 8.5 +/- 2.1 nM) caused a 4-35% (N = 8) increase (P less than 0.01) in the number of specific binding sites of [125I](-)pindolol. In contrast, addition of GTP did not cause any changes in the number of beta-adrenergic receptors in heart membranes from reserpinized animals (NA concentration less than 0.1 nM). In heart membranes from reserpinized animals, preincubation with NA (followed by washing) revealed a time- and concentration-dependent decrease with a maximum of 35-40% in the [125I](-)pindolol-binding sites. This agonist-mediated decrease in the number of receptors was prevented if GTP was also present in the NA-preincubation medium. It is concluded that NA can undergo tight binding to beta-adrenergic receptors in rat heart membranes. The heart-membrane preparations contain endogenous NA which, via tight agonist binding, is responsible for masking part of the beta-adrenergic receptor population.

Citing Articles

Chronic (-)-isoprenaline infusion down-regulates beta 1- and beta 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart.

Matthews J, Falckh P, Molenaar P, Summers R Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(2):213-25.

PMID: 8717163 DOI: 10.1007/BF00168760.


Beta-adrenoceptor regulation and functional responses in the guinea-pig following chronic administration of the long-acting beta 2-adrenoceptor agonist formoterol.

Kompa A, Molenaar P, Summers R Naunyn Schmiedebergs Arch Pharmacol. 1995; 351(6):576-88.

PMID: 7675115 DOI: 10.1007/BF00170156.


Independent regulation of beta 1- and beta 2-adrenoceptors.

Beer M, Hacker S, Poat J, Stahl S Br J Pharmacol. 1987; 92(4):827-34.

PMID: 2892556 PMC: 1853710. DOI: 10.1111/j.1476-5381.1987.tb11387.x.


Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.

Brodde O, Schemuth R, Brinkmann M, Wang X, Daul A, Borchard U Naunyn Schmiedebergs Arch Pharmacol. 1986; 333(2):130-8.

PMID: 2875397 DOI: 10.1007/BF00506515.


(+)-sotalol causes significant occupation of beta-adrenoceptors at concentrations that prolong cardiac repolarization.

Reid J, Duker G, ALMGREN O, Nerme V Naunyn Schmiedebergs Arch Pharmacol. 1990; 341(3):215-20.

PMID: 2160616 DOI: 10.1007/BF00169733.